Biogen (BIIB) option implied volatility movement into data
Tweet
Share
E-mail
Get Alerts BIIB Hot Sheet
Join SI Premium – FREE
Biogen (NASDAQ: BIIB) September weekly option implied volatility is at 225, October is at 110; compared to its 52-week range 29 to 97 into topline phase 3 data for Alzheimer's drug lecanemab.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Steel Dynamics (STLD) call put ratio 2.8 calls to 1 put into quarter results
- Intel (INTC) call put ratio 1.2 calls to 1 put as share price down 3.3%
- 3M Co. (MMM) call put ratio 8.9 calls to 1 put with q focus on July 170 calls into quarter results
Create E-mail Alert Related Categories
OptionsRelated Entities
OptionsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
